Urine Drug Testing in the Clinical Laboratory; Approved Guideline<\/p>\n","protected":false},"excerpt":{"rendered":"
NCCLS document T\/DM8-A\u2014 Urine Drug Testing in the Clinical Laboratory; Approved Guideline, is designed to aid the clinical laboratorian in developing procedures for the efficient and reliable analysis of urine to qualitatively determine the presence of certain controlled substances. This guideline addresses drug testing in the workplace and other environments such as the criminal justice system and rehabilitation facilities. Its primary objective is to assure that high quality standards are maintained within this important area of clinical laboratory analysis, where test results may affect a person’s reputation, employment status, or freedom, as well as the nonemergency diagnosis and treatment of substance abuse problems. This document conforms to the objective by addressing specimen collection and processing, methods of analysis, quality assurance, and the reporting and interpretation of results. Because the results of drug abuse detection analyses have obvious potential for use as evidence in legal proceedings, information is provided relating to forensic procedures used to safeguard the identity of the specimen, document the chain-of-custody, and assure proper use of analytical results. [NCCLS. Urine Drug Testing in the Clinical Laboratory; Approved Guideline. NCCLS document T\/DM8-A (ISBN 1-56238-372-8). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087, 1999.<\/p>\n","protected":false},"featured_media":1782,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_cat":[26],"product_tag":[],"yoast_head":"\n